Literature DB >> 12112197

Dopamine miracle: from brain homogenate to dopamine replacement.

Oleh Hornykiewicz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12112197     DOI： 10.1002/mds.10115

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  24 in total

1.  Parkinson disease: treatment of the nonmotor symptoms of Parkinson disease.

Authors:  Werner Poewe
Journal:  Nat Rev Neurol       Date:  2010-08       Impact factor: 42.937

Review 2.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 3.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

Review 4.  Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.

Authors:  D James Surmeier; Glenda M Halliday; Tanya Simuni
Journal:  Exp Neurol       Date:  2017-08-02       Impact factor: 5.330

Review 5.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

6.  IR-MALDESI mass spectrometry imaging of underivatized neurotransmitters in brain tissue of rats exposed to tetrabromobisphenol A.

Authors:  M Caleb Bagley; Måns Ekelöf; Kylie Rock; Heather Patisaul; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2018-10-13       Impact factor: 4.142

7.  Evaluation of the Cytotoxicity of Levodopa and its Complex with Hydroxypropyl-ß-Cyclodextrin (HP-ß-CD) to an Astrocyte Cell Line.

Authors:  Zarif Mohamed Sofian; Shazrin Shazira Shafee; Jafri Malin Abdullah; Hasnah Osman; Shariza Abdul Razak
Journal:  Malays J Med Sci       Date:  2014-12

8.  Dopamine: the rewarding years.

Authors:  Charles A Marsden
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 9.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

10.  Fas-associated factor 1 and Parkinson's disease.

Authors:  Ranjita Betarbet; Leah R Anderson; Marla Gearing; Tiffany R Hodges; Jason J Fritz; James J Lah; Allan I Levey
Journal:  Neurobiol Dis       Date:  2008-05-29       Impact factor: 5.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.